Yüksel Ürün/X
Mar 26, 2025, 14:26
Yüksel Ürün: Revolution in Metastatic Melanoma
Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Jedd D. Wolchok, et al. on X:
“20 years ago, metastatic melanoma meant death in a year.
Today?
- 10-yr Overall Survival: 43% (nivo+ipi).
- 10-yr Melanoma-Specific Survival: 52%.
This isn’t improvement. It’s a revolution. Believe in science.”
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Authors: Jedd D. Wolchok, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 13:29
Mar 29, 2025, 12:32
Mar 29, 2025, 12:06
Mar 29, 2025, 12:00
Mar 29, 2025, 11:58